M Z1 Pill - purple round, 6mm
Pill with imprint M Z1 is Purple, Round and has been identified as Zolpidem Tartrate 5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Zolpidem is used in the treatment of Insomnia and belongs to the drug class miscellaneous anxiolytics, sedatives and hypnotics. Risk cannot be ruled out during pregnancy. Zolpidem 5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
Images for M Z1
Zolpidem Tartrate
- Imprint
- M Z1
- Strength
- 5 mg
- Color
- Purple
- Size
- 6.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous anxiolytics, sedatives and hypnotics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 4 - Some potential for abuse
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
lactose anhydrous,
D&C Red No. 30,
calcium phosphate dibasic anhydrous,
FD&C Blue No. 2,
FD&C Yellow No. 6,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
sodium lauryl sulfate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00378-5305 (Discontinued) | Mylan Pharmaceuticals Inc. |
51079-0724 (Discontinued) | UDL Laboratories Inc. |
54868-0845 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related images for "M Z1"
More about zolpidem
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,051)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: miscellaneous anxiolytics, sedatives and hypnotics
- Breastfeeding
- En español
Patient resources
Other brands
Ambien, Ambien CR, Zolpimist, Edluar, Intermezzo
Professional resources
- Zolpidem monograph
- Zolpidem (FDA)
- Zolpidem Capsule (FDA)
- Zolpidem Extended Release (FDA)
- Zolpidem Sublingual (FDA)
Other brands
Ambien, Ambien CR, Zolpimist, Edluar, Intermezzo
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.